Abstract:Neuroendocrine tumors of the thymus (NETTs) were rare neoplasms, and were classified into 4 histological entities: typical and atypical carcinoids (ATCs), small-cell and large-cell neuroendocrine carcinomas. Studies have shown the biological behavior, survival and recurrence between these types were divergent, but the clinical features and optimal treatment modalities still remain controversial. We aim to evaluate the clinicopathological characteristics and survival outcomes of in ATCs patients, especially the value of postoperative radiotherapy and R0 resection. We used the SEER database [1973-2014] to identify patients who were diagnosed as ATCs. The clinic-pathologic data as well as the histologic features were recorded. Multivariate analyses by use of the Cox proportional hazards model were performed to evaluate the effect of covariate on OS. Kaplan-Meier survival curves were used to describe survival probability of OS. A total of 39 patients with primary ATCs were included. The median age was 57, the incidence was three times higher for men (29, 74.4%) than for women(10,25.6%). ATCs were more likely larger in size (mean 9.1 cm, SD=3.9). R0 resection was performed for 46.9% patients. 19 patients received postoperative radiotherapy. The mean survival (MS) time was 63.1 months. The 5-yr OS was 55.7%. OS was not significantly different between patients treated with postoperative radiotherapy (yes vs no, p=0.540), but significantly between patients treated with R0 resection (yes vs no, 5-yr OS: 80.8% vs 37.1%; p=0.012). For those received R0 resection, there were no significant differences in OS between patients undergone adjuvant radiotherapy (yes vs no, 5-yr OS:80.0% vs 57.10%; p=0.460). However, adjuvant radiotherapy showed a trend in increasing survival for patients who received R1/R2 resection (yes vs no, 5-yr OS: 75.0% vs 32.10%; p=0.152). Univariate Analysis showed female (HR=10.038, p=0.000), age older than sixty (HR=0.017, p=0.017), distant metastases (HR=1.470, p=0.024) and R1/R2 resection (HR=4.939, p=0.020) were independent risk factors for survival. Multivariable analysis showed female was associated with much higher risk of all-cause mortality (HR=5.711, p=0.025) compared with male. Patients with distant metastases had worse OS than non-metastases patients (HR=1.879, p=0.030), postoperative radiotherapy wasn’t associated with longer OS (HR=1.579, p=0.484). To our knowledge, this is the first report investigating the epidemiological factors and survival trends in ATCs based the SEER database. We suggest that ATCs primarily afflict males, usually in the fifth decade of life. R0 surgical resection is recommended for ATCs. Patients might benefit from R1/R2 resection plus adjuvant radiotherapy, and have an OS approximate to those who accept R0 resection alone. However, the role of postoperative radiotherapy for ATCs warrant prospective evaluation in clinical trials.

Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network

Oncological Outcome of Patients with Salivary Gland Cancer Treated with Surgery and Postoperative Intensity-Modulated Radiotherapy: a Retrospective Study

Carcinomas of the external auditory canal: management and results: a multicenter REFCOR propensity score matching study

Radiotherapy in the Management of Non-Metastatic Inflammatory Breast Cancers: A Retrospective Observational Study

Survival and Prognostic Factors after Adrenalectomy for Secondary Malignancy: A Combined Analysis of a French University Center Registry (Eurocrine ®) of 307 Patients and a French Nationwide Study of 2,515 Patients

Outcome of Postmastectomy Radiotherapy after Primary Systemic Treatment in Patients with Clinical T1-2N1 Breast Cancer.

Benefit of Postoperative Radiotherapy for Patients With Nonmetastatic Adrenocortical Carcinoma: A Population-Based Analysis

The Role of Radiotherapy in Patients with Resected Ampullary Carcinoma: Findings Based on the SEER Database

Adjuvant Radiotherapy After Surgical Resection Improves Local Control in Adrenocortical Carcinoma

Prognostic impact of extranodal extension in resected head and neck squamous cell carcinomas in the era of postoperative chemoradiation: A retrospective monocentric study

Twelve years after: The french national network on rare head and neck tumours (REFCOR)

The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapies

Clinical outcome and prognostic factors in recurrent oral squamous cell carcinoma after primary surgical treatment: a retrospective study

Adjuvant radiotherapy after surgical resection for adrenocortical carcinoma: A systematic review of observational studies and meta-analysis

The efficacy of adjuvant mitotane therapy and radiotherapy following adrenalectomy in patients with adrenocortical carcinoma: A systematic review and meta-analysis

The Value of Postoperative Radiation Therapy in Atypical Thymic Carcinoid Remains Unclear: A Population-Based Study

A Retrospective Study of Stage I to IIIa Lung Adenocarcinoma After Resection: What Is the Optimal Adjuvant Modality for Patients With an EGFR Mutation?

The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix

Preliminary Outcome of the Survival Rate and Possible Prognostic Factors for Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy.

Rectal Cancer Survival for Residual Carcinoma In Situ Vs. Pathologic Complete Response After Neoadjuvant Therapy

Prognostic Value of 18F-FDG PET/CT Assessment After Radiotherapy of Squamous Cell Carcinoma of the Anus in Patients from the National Multicentric Cohort FFCD-ANABASE